LncRNA MIR17HG drives cisplatin resistance partially via miR-138-5p/AKAP9 axis in cholangiocarcinoma. Tang L, Wang Y, Chen Y, Xu B, et al. Scand J Gastroenterol 2025 Jan 8:1-13. doi: 10.1080/00365521.2025.2450024.

Read + Share

Amedeo Smart

Independent Medical Education

Tang L, Wang Y, Chen Y, Xu B, et al. LncRNA MIR17HG drives cisplatin resistance partially via miR-138-5p/AKAP9 axis in cholangiocarcinoma. Scand J Gastroenterol 2025 Jan 8:1-13. doi: 10.1080/00365521.2025.2450024.
PMID: 39773276